Cargando…

Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes

The worldwide prevalence of obesity is steadily increasing, nearly doubling between 1980 and 2008. Obesity is often associated with insulin resistance, a major risk factor for type 2 diabetes mellitus (T2DM): a costly chronic disease and serious public health problem. The underlying cause of T2DM is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kimple, Michelle E, Neuman, Joshua C, Linnemann, Amelia K, Casey, Patrick J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081554/ https://www.ncbi.nlm.nih.gov/pubmed/24946790 http://dx.doi.org/10.1038/emm.2014.40

Ejemplares similares

Dietary polyunsaturated fatty acids and their metabolites: Implications for diabetes pathophysiology, prevention, and treatment
por: Neuman, Joshua C., et al.
Publicado: (2017)

Targeting the G protein-coupled estrogen receptor (GPER) in obesity and diabetes
por: Sharma, Geetanjali, et al.
Publicado: (2021)

Agonist-independent Gα(z) activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes
por: Schaid, Michael D., et al.
Publicado: (2020)

Prostaglandin E(2) Receptor, EP3, Is Induced in Diabetic Islets and Negatively Regulates Glucose- and Hormone-Stimulated Insulin Secretion
por: Kimple, Michelle E., et al.
Publicado: (2013)

Inhibitory G(i/O)-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics
por: Yudin, Yevgen, et al.
Publicado: (2018)

G protein-coupled receptors as new therapeutic targets for type 2 diabetes
por: Reimann, Frank, et al.
Publicado: (2015)

Adenosine receptors as emerging therapeutic targets for diabetic kidney disease
por: Pak, Eun Seon, et al.
Publicado: (2022)

SAT-168 A Secreted Protein Complement 1q Like-3 Protein Inhibits Insulin Secretion by an Adhesion G-Protein Coupled Receptor, BAI3 in Pancreatic β-Cells
por: Gupta, Rajesh, et al.
Publicado: (2019)

Engineering therapeutic antibodies targeting G-protein–coupled receptors
por: Jo, Migyeong, et al.
Publicado: (2016)

Emerging role of G9a in cancer stemness and promises as a therapeutic target
por: Haebe, Joshua R., et al.
Publicado: (2021)

TRP Channels as Therapeutic Targets in Diabetes and Obesity
por: Zsombok, Andrea, et al.
Publicado: (2016)

Cryo‐EM structure of G‐protein‐coupled receptor GPR17 in complex with inhibitory G protein
por: Ye, Fang, et al.
Publicado: (2022)

Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS‐1 (832/3) cell glucose‐stimulated insulin secretion
por: Sandhu, Harpreet K., et al.
Publicado: (2021)

Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes
por: Wisinski, Jaclyn A., et al.
Publicado: (2016)

G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
por: Xu, Shen, et al.
Publicado: (2019)

G protein estrogen receptor as a potential therapeutic target in Raynaud’s phenomenon
por: Fardoun, Manal, et al.
Publicado: (2022)

G protein-coupled receptors in cochlea: Potential therapeutic targets for hearing loss
por: Ma, Xiangyu, et al.
Publicado: (2022)

Targeting G protein coupled receptor-related pathways as emerging molecular therapies
por: Ghanemi, Abdelaziz
Publicado: (2015)

G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease
por: Divorty, Nina, et al.
Publicado: (2015)

Potential Therapeutic Targeting Neurotransmitter Receptors in Diabetes
por: Pan, Xiaohui, et al.
Publicado: (2022)

Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
por: Bakherad, Hamid, et al.
Publicado: (2020)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35
por: Quon, Tezz, et al.
Publicado: (2020)

Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels
por: Hutchings, Catherine J
Publicado: (2020)

G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases
por: Li, Nan, et al.
Publicado: (2022)

Insights into Nuclear G-Protein-Coupled Receptors as Therapeutic Targets in Non-Communicable Diseases
por: Gonçalves-Monteiro, Salomé, et al.
Publicado: (2021)

The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer
por: Hall, Keith A., et al.
Publicado: (2023)

Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
por: Leyva-Illades, Dinorah, et al.
Publicado: (2013)

Serotonin as a New Therapeutic Target for Diabetes Mellitus and Obesity
por: Oh, Chang-Myung, et al.
Publicado: (2016)

Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
por: Achari, Arunkumar E., et al.
Publicado: (2017)

G-protein signaling: back to the future
por: McCudden, C. R., et al.
Publicado: (2005)

An Investigation of Hierachical Protein Recruitment to the Inhibitory Platelet Receptor, G6B-b
por: Coxon, Carmen H., et al.
Publicado: (2012)

Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
por: Cavalli, Eugenio, et al.
Publicado: (2020)

Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019)

Free fatty acid receptors, G protein‐coupled receptor 120 and G protein‐coupled receptor 40, are essential for oil‐induced gastric inhibitory polypeptide secretion
por: Sankoda, Akiko, et al.
Publicado: (2019)

HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification
por: Kimple, Adam J., et al.
Publicado: (2012)

Emerging therapeutic targets for cerebral edema
por: Jha, Ruchira M., et al.
Publicado: (2021)

The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia
por: Röder, Bettina, et al.
Publicado: (2023)

Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer
por: Christianson, Joe, et al.
Publicado: (2021)

Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis
por: Okamoto, Yasuo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_r0d0cet5o1o05q1rcecror83tc